GET DAILY SIGNALSWhy Is GMR Solutions (GMRS) Stock Down 8.6% Today?
Key Takeaways
- Shares of GMRS fell about 8.6% to $11.37 in Monday trading, down from a prior close of $12.44.
- The decline comes hours before the company's third-quarter 2026 earnings release, scheduled for after the market close.
- Recent results have featured margin compression and a swing to a net loss, leaving investors cautious into the report.
- Reimbursement headwinds, rising labor and fuel costs, and a leveraged balance sheet remain persistent overhangs.
- The stock continues to trade well below its May 2026 IPO price, extending a year-to-date decline.
- Traders are watching the after-hours release and Tuesday's earnings call for adjusted EBITDA and guidance trends.
- For additional context, explore the Price Targets, Earnings, and Forecast pages for GMRS.
- Explore Trending AI Robots to see which AI-powered trading strategies are leading under current market conditions.
Opening Summary
GMR Solutions Inc. (GMRS), the nation's largest provider of emergency medical services and parent of ambulance operator American Medical Response, saw its shares plunge in Monday's session, falling roughly 8.6% to $11.37 from Friday's closing level of $12.44. The Lewisville, Texas-based company is scheduled to report third-quarter 2026 results after the closing bell, and the sell-off reflects investors de-risking ahead of a print that has historically been a source of volatility for the newly public EMS operator.
Pre-Earnings De-Risking Ahead of Q3 Results
The most immediate catalyst behind the move is the timing of the company's earnings calendar. GMRS is due to release third-quarter results after Monday's close, with a conference call scheduled for Tuesday morning. The market reaction suggests traders are unwilling to hold positions into a report that has disappointed before. In August, the company posted a second-quarter net loss of $28.3 million compared with a profit of $80.8 million a year earlier, reporting a loss of $1.84 per share against expectations for a profit. That earnings-driven move was followed by a prolonged post-earnings drift lower, a pattern that appears to be repeating itself as investors lighten exposure ahead of the next release.
Margin, Reimbursement, and Leverage Concerns
Beyond the earnings event itself, the decline reflects deeper worries about the company's profitability profile. Second-quarter adjusted EBITDA fell 11.8% year over year to about $285 million, pressured by lower No Surprises Act independent dispute resolution collections, IPO-related costs, and higher operating expenses. Wages and benefits rose 24.5%, while maintenance, fuel, and other direct costs climbed 21.1%. Reimbursement uncertainty tied to the expiration of ACA subsidies and a challenging payer mix has also weighed on sentiment, as has a capital structure still carrying roughly $2.9 billion in term loan debt, despite a recent $200 million debt paydown and a repricing that lowered net leverage to about 3.5 times.
Market Context and Trading Activity
The stock's weakness also fits within a broader period of post-IPO underperformance. Since listing in May 2026 at $15, GMRS has traded as low as roughly $9 and remains far below its 52-week high of $15.98. Turnover has been running above its recent average, with Friday's session printing roughly 810,000 shares versus a trailing average near 505,000, underscoring heightened positioning activity into the earnings event. The move lower in early trading pushed the shares toward the lower end of their recent range, a sign that sellers were controlling the tape ahead of the afternoon report.
What Comes Next for GMRS
Investors now turn their attention to the third-quarter release and the subsequent management commentary. Key areas of focus include the trajectory of adjusted EBITDA, transport volumes, reimbursement and payer-mix trends, and any updates to the company's full-year revenue and adjusted EBITDA guidance. Risks remain tilted toward continued cost inflation, reimbursement volatility, and the drag from a heavily leveraged balance sheet, while any stabilization in margins or stronger-than-expected guidance could ease near-term pressure. The earnings call scheduled for Tuesday morning will be central to determining whether the pre-earnings sell-off was an overreaction or a rational repricing of fundamentals.
Trending AI Robots
Tickeron's Trending AI Robots page offers a curated view of the platform's AI-driven trading bots. Tickeron provides hundreds of automated trading bots that monitor thousands of tickers, but only the strongest performers under current market conditions are featured in this section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to explore systematic approaches that adapt to shifting market dynamics. Visit the page to see which strategies are currently leading.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GMRS in upward trend: 10-day moving average moved above 50-day moving average on November 06, 2026
The 10-day moving average for GMRS crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GMRS as a result. In 4 of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for GMRS just turned positive on October 09, 2026. Looking at past instances where GMRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +9.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMRS advanced for three days, in 14 of 20 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 9 of 14 cases where GMRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for GMRS moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator moved out of overbought territory. In 1 of the 1 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 5 of 6 cases where GMRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
GMRS moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
GMRS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (204.532). P/E Ratio (-6.129) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.502) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. GMRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement